Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Epidermal Growth Factor Receptor 2 (HER2)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01534455
What this trial is testing

Efficacy and Tolerability of Eribulin Plus Lapatinib in Patients With Metastatic Breast Cancer (E-VITA)

Who this might be right for
Metastatic Breast Cancer
GBG Forschungs GmbH 43
Testing effectiveness (Phase 2)UnknownNCT05747326
What this trial is testing

Oral Vinorelbine and Capecitabine in Advanced HER2-negative Breast Cancer

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Not applicableLooking for participantsNCT04660435
What this trial is testing

To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer

Who this might be right for
Metastatic Breast CancerER Positive Breast CancerHER2-negative Breast Cancer
Fondazione Sandro Pitigliani 150
Large-scale testing (Phase 3)Active Not RecruitingNCT05038735
What this trial is testing

Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 210
Not applicableStudy completedNCT06833268
What this trial is testing

Real-world Outcomes of Patients With HER2+ Metastatic Breast Cancer After Treatment With Trastuzumab Deruxtecan

Who this might be right for
HER2-positive Breast Cancer
Daiichi Sankyo 228
Testing effectiveness (Phase 2)Looking for participantsNCT05872347
What this trial is testing

Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.

Who this might be right for
Breast Cancer Brain Metastases
Shanghai Pharmaceuticals Holding Co., Ltd 52
Very early researchUnknownNCT06224738
What this trial is testing

Human HER2-targeted Macrophages Therapy for HER2-positive Advanced Gastric Cancer With Peritoneal Metastases

Who this might be right for
Gastric Cancer
First People's Hospital of Hangzhou 9
Early research (Phase 1)Study completedNCT01351350
What this trial is testing

Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesHematologic Malignancies
Millennium Pharmaceuticals, Inc. 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT03609047
What this trial is testing

Adjuvant Palbociclib in Elderly Patients With Breast Cancer

Who this might be right for
Breast Cancer Stage IIBreast Cancer Stage III
European Organisation for Research and Treatment of Cancer - EORTC 366
Testing effectiveness (Phase 2)UnknownNCT02681562
What this trial is testing

Olaparib in Locally Advanced ER, PgR and HER2 Negative (Triple Negative) and in Locally Advanced Germline BRCA Mutation-positive Breast Cancer Patients

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Istituti Ospitalieri di Cremona 45
Not applicableLooking for participantsNCT07476170
What this trial is testing

Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China

Who this might be right for
HR+/HER2- Advanced or Metastatic Breast Cancer
Novartis Pharmaceuticals 14,000
Large-scale testing (Phase 3)Active Not RecruitingNCT04639986
What this trial is testing

Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Gilead Sciences 331
Testing effectiveness (Phase 2)Study completedNCT02628613
What this trial is testing

Neoadjuvant Paclitaxel Plus Epirubicin Versus Vinorelbine Plus Epirubicin in Breast Cancer With TEKT4 Variations

Who this might be right for
Breast Cancer
Fudan University 91
Large-scale testing (Phase 3)Ended earlyNCT04740918
What this trial is testing

Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Hoffmann-La Roche 96
Testing effectiveness (Phase 2)UnknownNCT05885776
What this trial is testing

Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI Research

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 48
Post-approval studies (Phase 4)Looking for participantsNCT05452213
What this trial is testing

Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients

Who this might be right for
Breast CancerBreast NeoplasmsBreast Neoplasm Female+4 more
Institut fuer Frauengesundheit 1,000
Large-scale testing (Phase 3)Looking for participantsNCT03201861
What this trial is testing

Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk Women

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Duct Carcinoma of Breast
RenJi Hospital 762
Not applicableLooking for participantsNCT06358625
What this trial is testing

Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Center Eugene Marquis 120
Testing effectiveness (Phase 2)UnknownNCT01210768
What this trial is testing

Pegylated Liposomal Doxorubicin and Cyclophosphamide in Her2-negative Stage I and II Breast Cancer Patients

Who this might be right for
Breast Cancer
TTY Biopharm 254
Not applicableUnknownNCT05893368
What this trial is testing

New Model for Integrating Person-based Care (PbC) in the Treatment of Advanced HER2-negative Breast Cancer

Who this might be right for
Advanced Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 50
Next Page